MENU

IKT Inhibikase Therapeutics Forecast, Technical & Fundamental Analysis

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

IKT is expected to report earnings to -10 cents per share on November 13

Inhibikase Therapeutics IKT Stock Earnings Reports
Q3'26
Est.
$-0.11
Q2'26
Est.
$-0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.08
Q3'25
Beat
by $0.01
The last earnings report on August 11 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 412.46K shares outstanding, the current market capitalization sits at 218.37M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTGD23.150.30
+1.33%
STKd 100% Bitcoin & 100% Gold ETF (BTGD)
SDG86.900.27
+0.31%
iShares MSCI Global Sustainable Development Goals ETF (SDG)
MMU9.490.01
+0.11%
Western Asset Managed Municipals Fund
ALRG30.89N/A
N/A
Allspring LT Large Core ETF (ALRG)
HYD49.02-0.32
-0.65%
VanEck High Yield Muni ETF (HYD)

IKT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with MLYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then MLYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-3.90%
MLYS - IKT
41%
Loosely correlated
+2.83%
EDIT - IKT
37%
Loosely correlated
+1.17%
BNTC - IKT
37%
Loosely correlated
-1.06%
VIR - IKT
37%
Loosely correlated
+2.00%
ENTA - IKT
36%
Loosely correlated
-0.58%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1000 N. West Street
Phone
+1 302 295-3800
Employees
35
Web
https://www.inhibikase.com
Inhibikase Therapeutics (IKT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com